Perrigo Company plc Restructuring Reserve
Perrigo Company plc (PRGO) had Restructuring Reserve of $76.70 million as of 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities
us-gaap:RestructuringReserve · last filed 2026-08-05
- 2026-06-27: Restructuring Reserve $76.70M.
- 2026-03-28: Restructuring Reserve $98.70M.
- 2025-12-31: Restructuring Reserve $45.20M.
- 2025-09-27: Restructuring Reserve $50.40M.
| Period end | Restructuring Reserve | Restructuring Reserve as first filed |
|---|---|---|
| 2026-06-27 | $76.70M 10-Q · filed 2026-08-05 | |
| 2026-03-28 | $98.70M 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $45.20M 10-Q · filed 2026-08-05 | |
| 2025-09-27 | $50.40M 10-Q · filed 2025-11-05 | |
| 2025-06-28 | $41.00M 10-Q · filed 2026-08-05 | |
| 2025-03-29 | $45.60M 10-Q · filed 2026-08-05 | |
| 2024-12-31 | $32.80M 10-Q · filed 2026-08-05 | |
| 2024-09-28 | $44.30M 10-Q · filed 2025-11-05 | |
| 2024-06-29 | $43.80M 10-Q · filed 2025-11-05 | |
| 2024-03-30 | $41.00M 10-Q · filed 2025-08-06 | |
| 2023-12-31 | $12.20M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $8.20M 10-Q · filed 2024-11-06 | |
| 2023-07-01 | $13.40M 10-Q · filed 2024-11-06 | |
| 2023-04-01 | $15.60M 10-Q · filed 2024-08-02 | |
| 2022-12-31 | $19.80M 10-K · filed 2026-02-26 | |
| 2022-10-01 | $19.30M 10-Q · filed 2023-11-07 | |
| 2022-07-02 | $13.50M 10-Q · filed 2023-11-07 | |
| 2022-04-02 | $8.20M 10-Q · filed 2023-08-08 | |
| 2021-12-31 | $6.90M 10-K · filed 2025-02-28 | |
| 2021-10-02 | $7.40M 10-Q · filed 2022-11-08 | |
| 2021-07-03 | $10.20M 10-Q · filed 2022-11-08 | |
| 2021-04-03 | $6.20M 10-Q · filed 2022-08-09 | |
| 2020-12-31 | $9.10M 10-K · filed 2024-02-27 | $9.50M 10-K · filed 2021-03-01 |
| 2020-09-26 | $7.50M 10-Q · filed 2021-11-12 | $7.90M 10-Q · filed 2020-11-05 |
| 2020-06-27 | $9.40M 10-Q · filed 2021-11-12 | $9.80M 10-Q · filed 2020-08-05 |
| 2020-03-28 | $16.00M 10-Q · filed 2021-08-11 | |
| 2019-12-31 | $19.50M 10-K · filed 2023-02-28 | $19.60M 10-K · filed 2020-02-27 |
| 2019-09-28 | $21.50M 10-Q · filed 2020-11-05 | |
| 2019-06-29 | $23.80M 10-Q · filed 2020-11-05 | $24.00M 10-Q · filed 2019-08-08 |
| 2019-03-30 | $20.50M 10-Q · filed 2020-08-05 | |
| 2018-12-31 | $23.70M 10-K · filed 2022-03-01 | $24.00M 10-K · filed 2019-02-27 |
| 2018-09-29 | $29.00M 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $12.70M 10-Q · filed 2019-11-06 | |
| 2018-03-31 | $12.40M 10-Q · filed 2019-08-08 | |
| 2017-12-31 | $21.40M 10-K · filed 2021-03-01 | |
| 2017-09-30 | $26.10M 10-Q · filed 2018-11-08 | |
| 2017-07-01 | $39.70M 10-Q · filed 2018-11-08 | |
| 2017-04-01 | $51.50M 10-Q · filed 2018-08-09 | |
| 2016-12-31 | $19.70M 10-K · filed 2020-02-27 | $14.70M 10-K · filed 2017-05-22 |
| 2016-10-01 | $10.30M 10-Q · filed 2017-11-09 | |
| 2016-07-02 | $12.20M 10-Q · filed 2017-11-09 | |
| 2016-04-02 | $13.00M 10-Q · filed 2017-08-10 | |
| 2015-12-31 | $20.70M 10-K · filed 2019-02-27 | |
| 2015-09-26 | $1.30M 10-Q/A · filed 2017-05-23 | |
| 2015-06-27 | $1.60M 10-K · filed 2018-03-01 | |
| 2015-03-28 | $3.60M 10-Q/A · filed 2017-05-22 | |
| 2014-12-27 | $3.20M 10-Q/A · filed 2017-05-23 | |
| 2014-09-27 | $3.90M 10-Q · filed 2015-02-05 | |
| 2014-06-28 | $16.40M 10-K · filed 2018-03-01 | |
| 2013-12-28 | $14.30M 10-Q · filed 2015-04-29 | |
| 2013-09-28 | $3.60M 10-Q · filed 2015-02-05 | |
| 2013-06-29 | $2.90M 10-Q · filed 2015-04-29 | |
| 2012-06-30 | $1.70M 10-K · filed 2015-08-13 | |
| 2011-06-25 | $0.00 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |